Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer have?
Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer has 196 citations in the OpenAlex counts ScholarIQ stores.
When was Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer published?
Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer has 2022 year in the ScholarIQ index.
What is the open-access status of Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer?
Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer has green oa status in the ScholarIQ index.
What is the DOI of Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer?
The DOI for Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer is on the source record.
What is the PMID of Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer?
The PMID for Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer is on the source record.
What is the OpenAlex record for Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer?
The OpenAlex for Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer is on the source record.